Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration
about
Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsSafety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adultsHuman immunodeficiency virus vaccine an update.Serum cytokine profiles associated with specific adjuvants used in a DNA prime-protein boost vaccination strategy.Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccineCD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcriptionRepeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefitElectroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developmentsEnhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines.Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial.The influence of delivery vectors on HIV vaccine efficacyLong-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients.HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses.HIV DNA Vaccine: Stepwise Improvements Make a Difference.Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppressionBacterial magnetic particles as a novel and efficient gene vaccine delivery system.HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection.Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine.Impact of pre-adapted HIV transmission.Non-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individuals.T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces.Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.X4 human immunodeficiency virus type 1 gp120 down-modulates expression and immunogenicity of codelivered antigens.Heterologous prime-boost vaccination.Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.DNA Immunization for HIV Vaccine Development.Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity.Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.Polyfunctional CD4+ T Cells As Targets for Tuberculosis VaccinationCross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination.
P2860
Q28394899-E435C498-E1DD-4E3D-9709-86C221A5FB0EQ28740321-42FE22F7-73B9-4EDE-9B60-D2728DD130D5Q30432382-9B87BCDF-71FD-4B35-816B-9F95DDB1D020Q31138173-9647A547-E307-45EF-984C-471A857D81BAQ33614476-BD9DEDB1-C1A3-41E7-AADA-5969BDFF705EQ33615194-41EAA4DF-7695-467A-8B77-4A7C0C3F4D85Q33698152-1AFA2D85-DA2C-4636-B7C5-B2A66BA8FE75Q33713435-DB2DEEFA-866E-4A5C-9650-CC0211C15527Q33778143-1568E135-74FC-43DC-B34F-E224B98822DFQ33784707-F0F9AD01-4AB2-4E6D-A320-0B7211E6ABB5Q34023588-4B09E1D8-BBA3-4403-A5E0-BD78F6297A70Q34077543-491AC880-288B-4ABE-9CBB-EBE277A372D2Q34099837-E17CE83A-B773-4246-82D8-72AF0C1529D0Q34988279-E6F7F188-736A-4259-B3B8-259FA3673675Q35115728-22F2DEBF-DD8A-40CB-96C2-E21441CEA40CQ35753766-2502767C-0D4A-484F-9BBC-3BB1038501EEQ35826742-6B26A567-3CC3-4C7F-B5CF-D88C91E8F533Q36081615-51A33C00-472D-4430-BEEA-AE754E45E32CQ36460540-31CF9634-0128-4509-A8EC-99401F4F60C5Q36767899-D33C30AC-88BA-476C-B97A-21CDE6BBF4F2Q36977750-604CFCD2-42AD-407E-AFFB-7E22359A9606Q36984267-8F76BD27-0F8B-4EF1-81FF-BF99F22F14C2Q37215858-FF7A2FE7-D05A-4CA3-97B8-19E4974793D1Q37333743-2B49D745-7E90-41FB-A539-310E11FBA540Q37351412-6695A1E6-B02D-4F82-B3A5-6D7CF16B694EQ37410867-EEA39D64-5609-4A13-96FA-DEA06FF881D5Q37509586-38914918-745C-455B-BBE7-0DC9116102FEQ38184579-316E6970-F91B-4F48-B4DC-A40605D770CAQ38581981-CE0912B5-BF66-407E-BDCD-894E1E5B6F84Q41526077-2595F7E5-D846-4405-B440-549F437C9395Q41933070-ADC3254C-BAC5-4BAA-B58F-864769C5ADCBQ42373425-4F8FC00A-F720-4DAA-AD3B-D3A48878650FQ42554027-28CE912C-110C-4C48-BB77-567A384D9DD8Q50944314-6F316A8D-8964-4B25-B986-1DEE2309BD9F
P2860
Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Multifunctional T-cell charact ...... ute and dose of administration
@en
type
label
Multifunctional T-cell charact ...... ute and dose of administration
@en
prefLabel
Multifunctional T-cell charact ...... ute and dose of administration
@en
P2093
P2860
P356
P1433
P1476
Multifunctional T-cell charact ...... ute and dose of administration
@en
P2093
Anju Bansal
Bethany Jackson
Jeffrey S Kennedy
Paul A Goepfert
Shixia Wang
P2860
P304
P356
10.1128/JVI.00068-08
P407
P577
2008-04-30T00:00:00Z